北美抗体检测市场预测至 2028 年 - COVID-19 影响和区域分析（按产品（试剂盒、化学品和试剂以及消耗品）、适应症（传染病、内分泌疾病、肿瘤、妊娠、心血管疾病、自身免疫性疾病等））和最终用户（诊断实验室、医院、生物制药公司以及学术和研究机构）
No. of Pages: 209 | Report Code: BMIRE00025437 | Category: Life Sciences
No. of Pages: 209 | Report Code: BMIRE00025437 | Category: Life Sciences
全球医疗保健系统面临的慢性病负担不断加重，推动了抗体检测市场的扩张在这个地区。诊断是任何治疗的第一步，检测试剂盒对于诊断任何病症以开始相关治疗至关重要。
根据疾病控制与预防中心 (CDC) 的数据，大约十分之六的人患有此病2019年美国至少有一种慢性病。由于各种疾病的发病率不断上升，对抗体检测试剂盒和耗材的需求不断增加，因为抗体检测是诊断多种病原体的重要标准。抗原表征对于了解和监测对感染原和疫苗的免疫反应也至关重要。
自身免疫性疾病的患病率增加，例如斑块状银屑病、阿狄森氏病、乳糜泻 - 狂犬病（麸质敏感性肠病） ）、皮肌炎、格雷夫斯病、桥本甲状腺炎、多发性硬化症、重症肌无力和恶性贫血也促进了北美抗体检测市场的增长。根据国际自身免疫研究所的自身免疫报告显示，宾厄姆功能医学纪念中心被认为是美国的重大健康危机。 5000 万美国人——其中 80% 是女性——患有一种或多种自身免疫性疾病。根据NCBI最新报告，两种常见自身免疫性疾病——系统性红斑狼疮（SLE）和干燥综合征的流行病学分析——美国的患病率高于其他国家。因此，疾病患病率的上升和早期诊断治疗的需求迫使制造商推出新型诊断试剂盒来满足未满足的需求。
凭借新的功能和技术，北美抗体供应商测试市场可以吸引新客户并扩大其在新兴市场的足迹。这一因素可能会推动北美抗体测试市场在预测期内实现有希望的复合年增长率。
北美抗体测试市场细分为产品、适应症和最终用户。根据产品，市场分为试剂盒、化学品和试剂以及消耗品。 2020年，试剂盒细分市场占据最大市场份额。根据迹象，北美抗体检测市场细分为传染病、内分泌疾病、肿瘤、妊娠、心血管疾病、自身免疫性疾病等。 2020年，传染病细分市场占据最大市场份额。根据最终用户，北美抗体检测市场分为诊断实验室、医院、生物制药公司以及学术和研究机构。 2020年，诊断实验室占据最大的市场份额。根据国家/地区，北美抗体检测市场分为美国、加拿大和墨西哥。 2020 年，美国占据最大市场份额。
雅培；艾博康公司；安捷伦科技公司； BD；生物拉德实验室有限公司； DiaSorin SpA； F. 霍夫曼拉罗什有限公司；赛默飞世尔科技有限公司；三一生物技术公司；和 ZEUS Scientific 是北美抗体检测市场的领先公司。
Strategic insights for North America Antibody Testing involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 3,308.90 Million |
| Market Size by 2028 | US$ 5,185.67 Million |
| Global CAGR (2021 - 2028) | 6.6% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By 产品
|
| Regions and Countries Covered | 北美
|
| Market leaders and key company profiles |
The regional scope of North America Antibody Testing refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The North America Antibody Testing Market is valued at US$ 3,308.90 Million in 2021, it is projected to reach US$ 5,185.67 Million by 2028.
As per our report North America Antibody Testing Market, the market size is valued at US$ 3,308.90 Million in 2021, projecting it to reach US$ 5,185.67 Million by 2028. This translates to a CAGR of approximately 6.6% during the forecast period.
The North America Antibody Testing Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Antibody Testing Market report:
The North America Antibody Testing Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Antibody Testing Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Antibody Testing Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
UK+442030260021, US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For North America Antibody Testing Market
